Fibroblast activation protein inhibitor PET for monitoring fibrotic diseases
Ugeskrift for Læger · 2025
DOI: 10.61409/v04250306 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ugeskrift for Læger, 2025. Verfasst von Rikke Helin Johnsen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Lunge- og Infektionsmedicinsk Afdeling, Københavns Universitetshospital - Nordsjællands Hospital. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Serine Endopeptidases, Gelatinases. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Fibroblast activation protein inhibitor (FAPI) PET was initially developed for cancer diagnostics; however, studies suggest that FAPI PET is a promising modality in various fibrotic diseases, including interstitial lung disease, fibrotic myocardial diseases, and rheumatic diseases such as rheumatoid arthritis, IgG4-related disease, and systemic scleroderma. There are limited studies on the subject, but this review finds that FAPI PET can accurately and specifically visualise active fibrosis and holds potential for monitoring treatment response and differentiation between inflammation and fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Lunge- og Infektionsmedicinsk Afdeling, Københavns Universitetshospital - Nordsjællands Hospital.
- Lungemedicinsk Sektion, Afdeling for Medicinske Sygdomme, Københavns Universitetshospital - Herlev og Gentofte Hospital.
- Afdeling for Klinisk Fysiologi og Nuklearmedicin, Københavns Universitetshospital - Rigshospitalet.
- Afdeling for Rygkirurgi, Led- og Bindevævssygdomme, Københavns Universitetshospital - Rigshospitalet.
Zitieren
APA
Johnsen, R. H., Christensen, K. B., Shaker, S. B., Mortensen, J., & Nielsen, C. T. (2025). Fibroblast activation protein inhibitor PET for monitoring fibrotic diseases. Ugeskrift for Læger. https://doi.org/10.61409/v04250306
Vancouver
Johnsen RH, Christensen KB, Shaker SB, Mortensen J, Nielsen CT. Fibroblast activation protein inhibitor PET for monitoring fibrotic diseases. Ugeskrift for Læger. 2025. doi:10.61409/v04250306
BibTeX
@article{Johnsen2025,
author = {Johnsen, Rikke Helin and Christensen, Katja Bjerregaard and Shaker, Saher B and Mortensen, Jann and Nielsen, Christoffer Tandrup},
title = {Fibroblast activation protein inhibitor PET for monitoring fibrotic diseases},
journal = {Ugeskrift for Læger},
year = {2025},
doi = {10.61409/v04250306}
}
EUVIMED